Definition of Immunization Immunization Schedule Success of Immunization Assessment of Success...
-
Upload
barbra-cross -
Category
Documents
-
view
243 -
download
6
Transcript of Definition of Immunization Immunization Schedule Success of Immunization Assessment of Success...
Definition of Immunization Immunization Schedule Success of Immunization
• Assessment of Success • Factors Influencing Success
The Cold Chain
Non specific
specific
skinmucous membranes
reflexes
genetic
sp. variation
race
anomalies
acquired
natural
passive ( transplacental )
active ( disease )
artificialactive
toxoidlive vacckilled vacc
passive homologous Abs
heterologous Abs
Resistance
Artificially acquired specific resistance
Vaccine: A suspension of attenuated live or killed
microorganisms or antigenic portion of these agent presented to a potential host to induce immunity and prevent disease
Toxoid: A modified bacterial toxin that has been
made nontoxic but remains the capacity to stimulate the formation of antitoxin
Antitoxin : An antibody derived from the serum of
animals from stimulation with specific antigen used to provide passive immunity
Definitions
Immunoglobulin:
An antibody-containing solution derived from large
pools of human plasma and used for passive
immunization.
• Attenuated strain of M.bovis. Safe in immunocompetent patient. 50 – 80% Protection against disseminated
tuberculosis and tuberculus meningitis 50% protection against pulmonary
tuberculosis in children and adults• Route: intradermal.
IPV: Inactivated poliovirus, trivalent: type
1,2 & 3
OPV : live attenuated poliovirus trivalent:
type 1,2 & 3
Vaccine administration:• IPV = IM• OPV = PO
Diphtheria and tetanus toxoids combined to a whole-cell pertussis (DPT)
DTaP = diphtheria and tetanus toxoids combined to a cellular pertussis vaccine (less systemic and local side effects than DPT for children <7yrs)
DT = for children <7yrs with contraindication to pertussis
Td = tetanus toxoid with1/3 -1/6 the dose of diphtheria toxoid for individuals >7yrs
• Three doses in the first year, interval 2mo.
• Consist of acapsular polysaccharide antigen
conjugated to a carrier (doesn’t protect
against the disease)
• Routine use of these vaccine has lead to a
95% decline in invasive Hib disease in
infancy and young children.
• Vaccine administration :IM
Haemophilus influenzae type B (Hib) vaccine
• Indications:• Routine• All infant of HBsAg positive mother• All children and adolescents not immunized• High risk group: o Health workers.o Haemodialysis, bleeding disorders.o Travellers to endemic areas.
• Live attenuated viruses..
• Monovalent measles vaccine, rubella vaccine
and measles/rubella MR formulations are
available.
• Vaccine administration: SC
MMR
The varicella vaccine is a live (attenuated) virus.
Vaccine administration: SC Two doses are always recommended.
Conjugate vaccine.
Quadrivalent (Serogroups A, C, W-135 and
Y)
MCV4 is administered (IM).
PCV Conjugate vaccine. Administered (IM).
MCV4
Birth
2 mo
4 mo
6 mo
9 mo
12 mo
18 mo
24 mo Schoolentry
BCG
DTaP1
DTaP2
DTaP3
Measles1(mono)
M2MR1
DTaPB1
HepAV2
DTaPB2
HepBV1
HibV1
HibV2
HibV3
OPV4
HibVB
OPVB2
IPV1
IPV2
IPV/OPV3
OPVB1
M4MR3 Varicella2
HepBV2
HepBV3
HepBV4
HepAV1
PCV1
PCV2
PCV3
PCVB
/Td
Rota
Rota
MCV4
MCV4
Varicella1 M3MR2
vaccineinformation.org
- Parents
- Staff
- Vaccine
KAPProximity
CommitmentSkill
EfficacyStability
( H.E. )( √ )
( Selection )( Training )
( Choice )( Cold Chain )
It is a temperature-controlled supply chain. It is
a system of storage , transport and distribution
of vaccines at a low temperature from
manufacturer to the actual vaccination site.
Cold chain
ManufacturerGround
TransportAirport Airplane
Airport
Terminal
Intermediate
Stops&Transfers
Distributor’sWarehouse
ConsumerOutlet
Consumer
Pharma / Biotech Cold Chain
Destination